The "monthly price" you see advertised is almost never what you'll pay over 12 months. Doses increase during titration (higher dose = higher cost at some providers). Lab work adds $100-400/year. Platform fees accumulate. This analysis shows the real 12-month cost for every major GLP-1 pathway — from $1,752 to $16,188.
GLP-1 treatment is a long-term commitment. Clinical trials showing 15-20% weight loss ran for 68-72 weeks. The medications work best when taken continuously at therapeutic dose.
That means you need a 12-month budget, not a first-month budget. Here's what each pathway actually costs when you account for dose escalation, ancillary fees, and the full treatment arc.
The 12-Month Cost Breakdown
Compounded Semaglutide (Budget Tier)
| Period | Monthly Cost | Cumulative |
|---|---|---|
| Months 1-3 (starting → mid dose) | $146-179/mo | $438-537 |
| Months 4-6 (therapeutic dose) | $146-199/mo | $876-1,134 |
| Months 7-12 (maintenance) | $146-199/mo | $1,752-2,328 |
| 12-month total | $1,752-2,328 |
Oral Wegovy (Brand-Name Pill)
| Period | Monthly Cost | Cumulative |
|---|---|---|
| Months 1-12 (flat pricing) | $149/mo | $1,788 |
| Add: Initial consultation | $0-150 (one-time) | $1,788-1,938 |
| 12-month total | $1,788-1,938 |
Compounded Tirzepatide
| Period | Monthly Cost | Cumulative |
|---|---|---|
| Months 1-3 (starting dose) | $199-275/mo | $597-825 |
| Months 4-6 (mid dose) | $249-350/mo | $1,344-1,875 |
| Months 7-12 (therapeutic) | $249-375/mo | $2,838-4,125 |
| 12-month total | $2,838-4,125 |
Zepbound Vials (LillyDirect)
| Period | Monthly Cost | Cumulative |
|---|---|---|
| Months 1-12 (flat pricing) | $299/mo | $3,588 |
| Add: Prescriber consultation | $0-200 (if needed) | $3,588-3,788 |
| 12-month total | $3,588-3,788 |
Wegovy Injectable (NovoCare Self-Pay)
| Period | Monthly Cost | Cumulative |
|---|---|---|
| Months 1-12 (flat pricing) | $349/mo | $4,188 |
| Add: Prescriber + labs | $200-400 | $4,388-4,588 |
| 12-month total | $4,388-4,588 |
Brand-Name With Insurance (Best Case)
| Period | Monthly Cost | Cumulative |
|---|---|---|
| Months 1-12 (with savings card) | $0-50/mo | $0-600 |
| Office visits (4-6 per year) | $20-50 copay each | $80-300 |
| Lab work (2-3 per year) | $0-50 copay each | $0-150 |
| 12-month total | $80-1,050 |
The Summary Table
| Pathway | 12-Month Range | Monthly Avg. |
|---|---|---|
| Insurance + savings card | $80-1,050 | $7-88 |
| Compounded semaglutide | $1,752-2,328 | $146-194 |
| Oral Wegovy | $1,788-1,938 | $149-162 |
| Compounded tirzepatide | $2,838-4,125 | $237-344 |
| Zepbound vials (LillyDirect) | $3,588-3,788 | $299-316 |
| Wegovy injectable (NovoCare) | $4,388-4,588 | $366-382 |
Hidden Costs Most People Miss
Lab Work
Responsible GLP-1 treatment includes baseline and periodic lab work — metabolic panel, A1C, liver function, lipid panel. Without insurance, expect $100-400/year for labs. Some telehealth platforms include lab kits; most don't.
Dose-Based Pricing Escalation
Some compounded GLP-1 providers charge more at higher doses. Your month-1 price at a starting dose may be $149, but your month-6 price at a therapeutic dose could be $249-349. Always ask about pricing at therapeutic dose before enrolling.
The "Pause Penalty"
If you pause treatment (vacation, financial reasons, side effects), some providers charge a re-enrollment or restart fee. Others lose your treatment history, requiring a new consultation. Ask about pause/restart policies upfront.
HSA/FSA Tax Advantage
Don't forget the positive hidden factor: if you use HSA/FSA funds, your effective cost drops 20-35%. A $2,400/year program becomes $1,560-1,920 in real after-tax dollars. See our HSA/FSA guide.
Compare All-Inclusive GLP-1 Programs
Affiliate links · Prices verified March 2026
The Bottom Line
GLP-1 treatment over 12 months ranges from under $100 (with excellent insurance) to around $4,600 (brand-name self-pay). For most self-pay patients, the practical range is $1,750-4,000.
Context matters: the average cost of obesity-related healthcare in the US is estimated at $1,800-3,500 per year in excess medical expenses. For many patients, GLP-1 treatment costs less than the health conditions it addresses.